Case Report

Metastatic gastric adenocarcinoma in a pregnant woman

Volume: 4 Number: 4 October 4, 2018
EN

Metastatic gastric adenocarcinoma in a pregnant woman

Abstract

Gastric cancers occur in only 0.025% to 0.1% of all pregnancies. We present a pregnant woman with gastric adenocarcinoma associated with bone metastasis. She is 36-year-old (gravida:4, para:0) 16-week pregnancy, complaining of nausea, vomiting, weight loss (~15 kg) and low back pain. Although the patient considered the condition to be related with pregnancy and underestimated its importance. She had high erythrocyte sedimentation rate (107 mm/h) and anemia (hemoglobin = 9.4 gr/dl). Lumbar magnetic resonance imaging showed L4 vertebrae malign compression fracture and diffuse bone metastasis. Because of the patient's melena, esophagogastroduodenoscopy was performed and biopsy result was reported as stomach adenocarcinoma. It is important to evaluate the symptoms of low back pain and pregnancy related symptoms carefully and do not cause delays in diagnosis due to overlapping symptoms. 

Keywords

References

  1. [1] Franklin ME, Conner-Kerr T. An analysis of posture and back pain in the first and third trimesters of pregnancy. J Orthop Sports Phys Ther 1998;28:133-8.
  2. [2] Ritchie JR. Orthopedic considerations during pregnancy. Clin Obstet Gynecol 2003;46:456-66.
  3. [3] Kristiansson P, Svardsudd K, Von Schoultz B. Serum relaxin, symphyseal pain, and back pain during pregnancy. Am J Obstet Gynecol 1996;175:1342-7.
  4. [4] Chan YL, Lam WW, Lau TK. Back pain in pregnancy: magnetic resonance imaging correlation. Clin Radiol 2002;57:1109-12.
  5. [5] Pacheco S, Norero E, Canales C, Martínez JM, Herrera ME, Muñoz C, et al. The rare and challenging presentation of gastric cancer during pregnancy: a report of three cases. J Gastric Cancer 2016;16:271-6.
  6. [6] Carvalho MECC, Lima LC, de Lira Terceiro CA, Pinto DRL, Silva MN, Cozer GA, et al. Low back pain during pregnancy. Rev Bras Anestesiol 2017;67:266-70.
  7. [7] Cardonick E, Lacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91.
  8. [8] Nishie H, Mizushima T, Suzuki Y, Fukusada S, Inoue T, Kachi K, et al. Chemotherapy treatment of a pregnant woman with progressive gastric cancer. Intern Med. 2015;54:1207-12.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Case Report

Publication Date

October 4, 2018

Submission Date

December 18, 2017

Acceptance Date

January 19, 2018

Published in Issue

Year 2018 Volume: 4 Number: 4

APA
Büyükavcı, R., Apaydın, H., & Aktürk, S. (2018). Metastatic gastric adenocarcinoma in a pregnant woman. The European Research Journal, 4(4), 444-447. https://doi.org/10.18621/eurj.368205
AMA
1.Büyükavcı R, Apaydın H, Aktürk S. Metastatic gastric adenocarcinoma in a pregnant woman. Eur Res J. 2018;4(4):444-447. doi:10.18621/eurj.368205
Chicago
Büyükavcı, Raikan, Hakan Apaydın, and Semra Aktürk. 2018. “Metastatic Gastric Adenocarcinoma in a Pregnant Woman”. The European Research Journal 4 (4): 444-47. https://doi.org/10.18621/eurj.368205.
EndNote
Büyükavcı R, Apaydın H, Aktürk S (October 1, 2018) Metastatic gastric adenocarcinoma in a pregnant woman. The European Research Journal 4 4 444–447.
IEEE
[1]R. Büyükavcı, H. Apaydın, and S. Aktürk, “Metastatic gastric adenocarcinoma in a pregnant woman”, Eur Res J, vol. 4, no. 4, pp. 444–447, Oct. 2018, doi: 10.18621/eurj.368205.
ISNAD
Büyükavcı, Raikan - Apaydın, Hakan - Aktürk, Semra. “Metastatic Gastric Adenocarcinoma in a Pregnant Woman”. The European Research Journal 4/4 (October 1, 2018): 444-447. https://doi.org/10.18621/eurj.368205.
JAMA
1.Büyükavcı R, Apaydın H, Aktürk S. Metastatic gastric adenocarcinoma in a pregnant woman. Eur Res J. 2018;4:444–447.
MLA
Büyükavcı, Raikan, et al. “Metastatic Gastric Adenocarcinoma in a Pregnant Woman”. The European Research Journal, vol. 4, no. 4, Oct. 2018, pp. 444-7, doi:10.18621/eurj.368205.
Vancouver
1.Raikan Büyükavcı, Hakan Apaydın, Semra Aktürk. Metastatic gastric adenocarcinoma in a pregnant woman. Eur Res J. 2018 Oct. 1;4(4):444-7. doi:10.18621/eurj.368205